Advertisement

Biochemical Modulation of Fluoropyrimidines: the “Giscad” Studies

  • R. Labianca
  • G. Pancera
  • S. Barni
  • S. Cascinu
  • G. Comella
  • P. Foa
  • G. Martignoni
  • A. Zaniboni
  • G. Giaccon
  • G. Luporini
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 339)

Abstract

GISCAD was established in July 1990, following the positive experience of the Medical Therapy Group of FONCAD (Italian Task Force against Digestive Tract Cancer).

Keywords

Gastric Cancer Colorectal Cancer Folinic Acid Biochemical Modulation Digestive Tract Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. Labianca, G. Pancera, E. Aitini, S. Barni, A. Beretta, G.D. Beretta, B. Cesana, G. Cornelia, L. Cozzaglio, M. Cristoni, P. Spagnolli, L. Frontini, O. Gottardi, G. Martignoni, R. Scapaticci, F. Smerieri, M. Vinci, A. Zadro, A. Zaniboni, and G. Luporini: “Folinic Acid + 5-Fluorouracil (5FU) Versus Equidose 5FU in Advanced Colorectal Cancer. Phase III Study of GISCAD (Italian Group for the Study of Digestive Tract Cancer”. Ann. Oncol. 2: 673–679 (1991).PubMedGoogle Scholar
  2. P. Piedbois, M. Buyse, Y. Rustum, D. Machover, C. Erlichman, R.N. Carlson, F. Valone, R. Labianca, J.H. Doroshow and N. Petrelli: “Modulation of Fluorouracil by Leucovorin in Patients with Advanced Colorectal Cancer: Evidence in Terms of Response Rate”. J. Clin. Oncol. 10: 896–903 (1992).Google Scholar
  3. S. Nadler and P.M. Niernik: “Clinical Update on the Role of Fluorouracil and Recombinant Interferon-alpha 2a in the Treatment of Colorectal Carcinoma”. Semin. Oncol. 17: 16–21 (1990).Google Scholar
  4. R. Labianca, G. Pancera, L. Tedeschi, G. Dallavalle, and G. Luporini: “High-dose Alpha 2b Interferon + Folinic Acid in the Modulation of 5-Fluorouracil. A Phase II Study in Advanced Colorectal Cancer with Evidence of an Unfavorable Cost/Benefit Ratio”. Tumori, 78: 32–34 (1992).PubMedGoogle Scholar
  5. C. Allegra: “Clinical Drug Resistence”. ASCO Editorial Booklet, 197–229 (1990).Google Scholar
  6. M.A. Poon, M.J. O’Connell and H.S. Wieand: Biochemical Modulation of Fluorouracil with Leucovorin. Confirmatory Evidence of Improved Therapeutic Efficacy in Advanced Colorectal Cancer”. J. Clin. Oncol. 9: 1967–1972 (1991).PubMedGoogle Scholar
  7. J. Gerstner, M.J. O’Connell, H.S. and H.S. Nieand: “A Prospectively Randomized Clinical Trial Comparing 5FU Combined with Either High or Low Dose Leucovorin for the Treatment of Advanced Colorectal Cancer”. Proc. ASCO 404 (1991).Google Scholar
  8. G. Pancera, R. Labianca, Y.M. Rustum, M. Clerici and G. Luporini: “Biochemical Modulation of 5-Fluorouracil with 4-hours Infusion of Folinic Acid: A Pilot Study in Advanced Colorectal Cancer”. Proc. ASCO 494 (1991).Google Scholar
  9. G. Pancera, R. Labianca, S. Samori, G. Mortara, M. Pirovano, G. Giaccon, A.C. Luporini, D. Tabiadon, G. Dallavalle and G. Luporini: “Chemioterapia Locoregionale e Sistemica nelle Metastasi Epatiche da Carcinoma del Colon-Retto”. X Riunione AIOM, Pordenone, 4–7 Novembre (1992).Google Scholar
  10. J.L. Grem, N. McAtee, R.F. Murphy: “A Pilot Study of Interferon Alpha 2a in Combination with Fluorouracil Plus High-Dose Leucovorin in Metastatic Gastrointestinal Carcinoma”. J. Clin. Oncol. 9: 1811–1917 (1991).PubMedGoogle Scholar
  11. S. Cascinu, A. Fedeli, S. Luzi Fedeli and G. Catalano: “Double Biochemical Modulation of 5-Fluorouracil by Leucovorin and Cyclic Low-dose Interferon Alpha-2b in Advanced Colorectal Cancer Patients”. Ann. Oncol. 3: 489–491, (1992).PubMedGoogle Scholar
  12. D. Machover, X. Grison, E. Goldschmidt, J. Zittoun, J. Plotz and G. Metzger: “Fluorouracil Combined with the Pure (65) Stereoisomer of Folinic Acid in High-dose for Treatment of Patients with Advanced Colorectal Carcinoma: A Phase I-II Study”. J.N.C. I. 5: 321–327, 1992.Google Scholar
  13. G. Pancera, D. Nitti, D. Civalleri, S. Marsoni, R. Labianca, M. Lise, V. Bachi and G. Luporini: “A Retrospective Analyis of 119 Patients with Resected Metastases from Colorectal Cancer: Is There a Role for Adjuvant Chemotherapy?”. Proc. ASCO 524, 1992.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • R. Labianca
    • 1
  • G. Pancera
    • 1
  • S. Barni
    • 1
  • S. Cascinu
    • 1
  • G. Comella
    • 1
  • P. Foa
    • 1
  • G. Martignoni
    • 1
  • A. Zaniboni
    • 1
  • G. Giaccon
    • 1
  • G. Luporini
    • 1
  1. 1.Division of Medical OncologySan Carlo Borromeo HospitalMilanItaly

Personalised recommendations